Synnovation Therapeutics plans to hire 40+ by 2026

WILMINGTON — Synnovation Therapeutics, a precision oncology company established by former Incyte researchers, has received state taxpayer-backed grants to help fuel the next stage of growth at The Innovation Space. Founded in 2021, Synnovation Therapeutics is a developer of therapies designed to target key gene mutations and other pathways implicated with cancer. Right now, the start-up

Already a subscriber? Log in

To continue reading this article ...

Subscribe to Delaware Business Times right now and get access to subscriber-only content like this article. Plus get 24 issues of DBT via print or digital, special bonus issues, and discounted registration for our in-person events.

– Digital Partners -